SEC Form D · filed November 20, 2019
PIERIS PHARMACEUTICALS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Stephen S. Yoder · Boston, MAExec · DirectorMichael S. Richman · Boston, MADirectorRaymond Lane · San Francisco, CAExec · DirectorMartin Matern · Luxembourg, LuxembourgDirectorAhmed S. Mousa · Boston, MAExecJames S. Geraghty · Boston, MADirectorAnn S. Barbier, M.D., Ph.D · Boston, MADirectorHitto R. Kaufmann, Ph.D · Boston, MAExecChristopher S. Kiritsy · Boston, MADirectorPeter S. Kiener, D.Phil · Boston, MADirectorMatthew L. Sherman, M.D · Boston, MADirectorMaya R. Said, Sc.D · Boston, MADirectorTom R. Bures · Boston, MAExecJean-Pierre S. Bizzari, M.D · Boston, MADirectorRob Keve · Hoboken, NJDirectorMichael Bryzek · Hoboken, NJExec · DirectorAhmed S. Mousa · Boston, MAExecJames S. Geraghty · Boston, MADirectorAnn S. Barbier, M.D., Ph.D · Boston, MADirectorHitto R. Kaufmann, Ph.D · Boston, MAExecChristopher S. Kiritsy · Lexington, MADirectorPeter S. Kiener, D.Phil · Boston, MADirectorMatthew L. Sherman, M.D · Boston, MADirectorMaya R. Said, Sc.D · Boston, MADirectorTom R. Bures · Boston, MAExecJean-Pierre S. Bizzari, M.D · Boston, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗